"Lonnel Coats, President and Chief Executive Officer of Eisai Inc., stated, "Eisai is committed to collaborating with Arena to address the FDA's requests. Obesity is an epidemic in America, and our goal is to bring lorcaserin to physicians and patients who need additional weight loss options."
With Eisai's backing, ARNA will have a deep pocket to draw from !
In the meantime, in Asia this morning 10/25/2010, Eisai share price jumps after clarification of FDA CRL is understood: http://www.google.com/finance?q=TYO:4523
No comments:
Post a Comment